Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

164 trials

NCT06894654
Recruiting
DERMATOMICS: Identifying Regulators of Skin Homeostasis
Not applicable · United Kingdom · 2 sites
Registry update: 14 Aug 2026
NCT06888960
Recruiting
Safety Study of CC312 in Autoimmune Disease Patients
Early phase 1 · China · 1 site
Registry update: 17 Sept 2025
NCT06733935
Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Phase 1/2 · United States · 12 sites
Registry update: 30 Oct 2026
NCT06379646
Recruiting
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
Not applicable · China · 1 site
Registry update: 22 Oct 2026
NCT06182293
Recruiting
Periodontal Microbiota in Systemic Sclerosis
Not applicable · France · 1 site
Registry update: 19 Aug 2026
NCT06548607
Recruiting
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
Early phase 1 · China · 1 site
Registry update: 6 Mar 2026
NCT07085676
Recruiting
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Phase 1 · Israel · 1 site
Registry update: 6 May 2026
NCT05785065
Recruiting
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Phase 2 · Canada · 3 sites
Registry update: 29 Sept 2026
NCT03800017
Recruiting
Skeletal Muscle Function in Interstitial Lung Disease
Not applicable · Canada · 1 site
Registry update: 15 May 2026
NCT06434363
Recruiting
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Phase 1/2 · United States · 2 sites
Registry update: 3 Nov 2026
NCT06328777
Recruiting
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Phase 2/3 · United States · 10 sites
Registry update: 16 Oct 2026
2023-510255-34-00
Recruiting
Calcinosis cutis in SSc patients treated with sodium thiosulfate assessed by biomarkers and imaging
Phase 4 · Denmark · 2 sites
Registry update: 14 Apr 2026
NCT06414135
Recruiting
Relmacabtagene Autoleucel for the Treatment of Systemic Sclerosis
Phase 1 · China · 1 site
Registry update: 15 Aug 2024
NCT06387654
Recruiting
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
Not applicable · France · 1 site
Registry update: 17 Mar 2026
NCT06133244
Recruiting
Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)
Not applicable · Netherlands · 1 site
Registry update: 28 May 2024
NCT06195072
Recruiting
Platform Clinical Study for Conquering Scleroderma
Phase 2 · Austria, Belgium, Germany, Denmark, Spain, France, Italy, Netherlands, Norway, Poland, Portugal, United States · 81 sites
Registry update: 18 Aug 2026
NCT06503224
Recruiting
An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
Not applicable · China · 1 site
Registry update: 24 Apr 2025
NCT06308978
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Phase 1 · France, United Kingdom, Sweden, United States · 21 sites
Registry update: 22 May 2026
NCT06249438
Recruiting
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Phase 1 · China · 1 site
Registry update: 25 Jul 2025
NCT06339957
Recruiting
Rheumatology Diet Study
Not applicable · United States · 1 site
Registry update: 6 Dec 2024

Ordered by registry start date. Freshness and sponsorship never change the order.